About
Apixaban is a direct oral anticoagulant (DOAC) that selectively and reversibly inhibits Factor Xa, a key enzyme in the coagulation cascade. By inhibiting Factor Xa, apixaban prevents the formation of thrombin and subsequent clot formation. This mechanism of action provides effective anticoagulation without the need for routine coagulation monitoring, unlike traditional vitamin K antagonists. It is widely used for the prevention and treatment of various thromboembolic conditions.
Its therapeutic applications include preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing recurrent DVT and PE. Apixaban offers a predictable pharmacokinetic profile and a relatively low risk of major bleeding compared to some other anticoagulants, making it a valuable option in clinical practice.
Uses
- Prevention of stroke and systemic embolism in non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT).
- Treatment of pulmonary embolism (PE).
- Prevention of recurrent DVT and PE.
Directions For Use
Take this medication orally twice daily, with or without food, as prescribed by your doctor. Do not stop taking it without consulting your physician.
Benefits
- Reduces risk of stroke in AFib.
- Prevents and treats DVT/PE.
- No routine blood monitoring required.
- Predictable anticoagulant effect.
- Lower risk of major bleeding (compared to warfarin).
- Convenient oral administration.
Side Effects
- Bleeding (e.g., nosebleeds, bruising, gastrointestinal)
- Nausea
- Anemia
- Rash
- Dizziness
- Fatigue
- Abdominal pain
- Minor cuts bleeding longer
- Hematuria (blood in urine)
- Epistaxis (nosebleed)
- Gingival bleeding
- Hypersensitivity reactions (rare)
Safety Measures
- Alcohol - Limit alcohol intake as it may increase the risk of bleeding, especially gastrointestinal bleeding, when combined with apixaban.
- Pregnancy - Not recommended during pregnancy due to potential for fetal bleeding and lack of adequate studies.
- Breastfeeding - Not recommended during breastfeeding as it is unknown if apixaban is excreted in human milk and could harm the infant.
- Liver - Use with caution in patients with moderate to severe hepatic impairment; not recommended in severe liver disease.
- Kidney - Dose adjustment may be required in patients with severe renal impairment; not recommended in end-stage renal disease.
- Lung - Generally safe for use in patients with lung conditions; specifically used for pulmonary embolism treatment.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!